Your browser doesn't support javascript.
loading
Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer.
Nalio Ramos, Rodrigo; Missolo-Koussou, Yoann; Gerber-Ferder, Yohan; Bromley, Christian P; Bugatti, Mattia; Núñez, Nicolas Gonzalo; Tosello Boari, Jimena; Richer, Wilfrid; Menger, Laurie; Denizeau, Jordan; Sedlik, Christine; Caudana, Pamela; Kotsias, Fiorella; Niborski, Leticia L; Viel, Sophie; Bohec, Mylène; Lameiras, Sonia; Baulande, Sylvain; Lesage, Laëtitia; Nicolas, André; Meseure, Didier; Vincent-Salomon, Anne; Reyal, Fabien; Dutertre, Charles-Antoine; Ginhoux, Florent; Vimeux, Lene; Donnadieu, Emmanuel; Buttard, Bénédicte; Galon, Jérôme; Zelenay, Santiago; Vermi, William; Guermonprez, Pierre; Piaggio, Eliane; Helft, Julie.
Affiliation
  • Nalio Ramos R; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Missolo-Koussou Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Gerber-Ferder Y; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Bromley CP; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.
  • Bugatti M; Department of Pathology, University of Brescia, Brescia 25123, Italy.
  • Núñez NG; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Tosello Boari J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Richer W; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Menger L; PSL University, Institut Curie Research Center, INSERM U932, 75005 Paris, France.
  • Denizeau J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Sedlik C; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Caudana P; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Kotsias F; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Niborski LL; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Viel S; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Bohec M; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France.
  • Lameiras S; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France.
  • Baulande S; PSL University, Institut Curie Research Center, Institut Curie Genomics of Excellence Platform, 75005 Paris, France.
  • Lesage L; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.
  • Nicolas A; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.
  • Meseure D; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.
  • Vincent-Salomon A; PSL University, Institut Curie Hospital, Department of Pathology, 75005 Paris, France.
  • Reyal F; PSL University, Institut Curie Hospital, Department of Surgery, 75005 Paris, France.
  • Dutertre CA; Université Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France.
  • Ginhoux F; Université Paris-Saclay, Institut Gustave Roussy, INSERM U1015, Villejuif, France; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore 138648, Singapore.
  • Vimeux L; University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France.
  • Donnadieu E; University of Paris, Institut Cochin, INSERM U1016, CNRS UMR 8104, 75014 Paris, France.
  • Buttard B; INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Laboratory of Integrative Cancer Immunology, Paris, France.
  • Galon J; INSERM, Sorbonne Université, Université de Paris, Centre de Recherche des Cordeliers, Laboratory of Integrative Cancer Immunology, Paris, France.
  • Zelenay S; Cancer Inflammation and Immunity Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Manchester, UK.
  • Vermi W; PSL University, Institut Curie Research Center, INSERM U932, 75005 Paris, France; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Guermonprez P; Université de Paris, Centre for Inflammation Research, CNRS ERL8252, INSERM1149, Paris, France.
  • Piaggio E; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France.
  • Helft J; PSL University, Institut Curie Research Center, INSERM U932 & SiRIC, Translational Immunotherapy Team, 75005 Paris, France. Electronic address: julie.helft@inserm.fr.
Cell ; 185(7): 1189-1207.e25, 2022 03 31.
Article in En | MEDLINE | ID: mdl-35325594
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Macrophages Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Cell Year: 2022 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Macrophages Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Cell Year: 2022 Type: Article Affiliation country: France